REVIEW ON LOSARTAN INDUCED HYPONATREMIA
American Journal of Medical and Natural Sciences · 21.01.2026 · 16-18
DOI: 10.70604/journal.v7i1.25 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical and Natural Sciences, online erschienen am 21.01.2026. Verfasst von Indhu Harini S. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Hyponatremia is a frequently encountered electrolyte imbalance associated with significant morbidity and mortality. While diuretics, selective serotonin reuptake inhibitors (SSRIs), and anticonvulsants are well-recognized causes, angiotensin II receptor blockers (ARBs), particularly losartan, have also been implicated in rare cases. This review explores the potential mechanisms, clinical evidence, risk factors, diagnostic considerations, and management strategies related to losartan-induced hyponatremia. Awareness of this uncommon yet clinically significant adverse effect is essential for early recognition and prevention of complications.
Zitieren
APA
S, I. H. (2026). REVIEW ON LOSARTAN INDUCED HYPONATREMIA. American Journal of Medical and Natural Sciences, 16-18. https://doi.org/10.70604/journal.v7i1.25
Vancouver
S IH. REVIEW ON LOSARTAN INDUCED HYPONATREMIA. American Journal of Medical and Natural Sciences. 2026:16-18. doi:10.70604/journal.v7i1.25
BibTeX
@article{S2026,
author = {S, Indhu Harini},
title = {REVIEW ON LOSARTAN INDUCED HYPONATREMIA},
journal = {American Journal of Medical and Natural Sciences},
year = {2026},
pages = {16--18},
doi = {10.70604/journal.v7i1.25}
}
EUVIMED